Welcome to the latest issue of the Medical Technology magazine
In this issue’s cover story, we dive into the topic of genomic testing. With approximately 37% of critically ill newborn genomes having a causal genetic disease, researchers and companies are using whole genome sequencing (WGS) to develop new programmes and tools.
We also look at the future of tissue regeneration and interview Erez Ben Zvi, Stratasys’s Vice President of Medical, about the promise of 3D bioprinting on regenerative medicine.
All this and the latest medical device industry news, comment, and analysis from GlobalData.
Catherine Longworth, Editor
Follow us on Twitter